A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression

Psychopharmacology

Volumn 231, Issue 4, 2014, Pages 685-693

  Zhang, Chen ^a,b   Li, Zezhi ^c,d   Wu, Zhiguo ^a   Chen, Jun ^a   Wang, Zuowei ^a   Peng, Daihui ^a   Hong, Wu ^a   Yuan, Chengmei ^a   Wang, Zhen ^a   Yu, Shunying ^a   Xu, Yifeng ^a   Xu, Lin ^b   Xiao, Zeping ^a   Fang, Yiru ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d Mental Health Centre of Hongkou District   (China)

Author keywords

Genetic predictor; GRIN2B; Major depressive disorder; Treatment resistant depression

Indexed keywords

ADULT; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HAPLOTYPES; HUMANS; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84893956740     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3297-0     Document Type: Article

References (43)

1. Aan Het Rot M, Zarate CA Jr, Charney DS, Mathew SJ (2012) Ketamine for depression: where do we go from here? Biol Psychiatry 72:537-547
2. Alonso P, Gratacos M, Segalas C, Escaramis G, Real E, Bayes M, Labad J, Lopez-Sola C, Estivill X, Menchon JM (2012) Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder. J Psychiatry Neurosci 37:273-281
3. Altamura CA, Mauri MC, Ferrara A, Moro AR, D'Andrea G, Zamberlan F (1993) Plasma and platelet excitatory amino acids in psychiatric disorders. Am J Psychiatry 150:1731-1733
4. Aragam N, Wang KS, Anderson JL, Liu X (2013) TMPRSS9 and GRIN2B are associated with neuroticism: a genome-wide association study in a European sample. J Mol Neurosci 50:250-256
5. Arnold PD, Macmaster FP, Hanna GL, Richter MA, Sicard T, Burroughs E, Mirza Y, Easter PC, Rose M, Kennedy JL, Rosenberg DR (2009) Glutamate system genes associated with ventral prefrontal and thalamic volume in pediatric obsessive-compulsive disorder. Brain Imaging Behav 3:64-76
6. Baskaran A, Milev R, McIntyre RS (2012) The neurobiology of the EEG biomarker as a predictor of treatment response in depression. Neuropharmacology 63:507-513
7. Berlim MT, Turecki G (2007) Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry 52:46-54
8. Bulayeva K, Lencz T, Glatt S, Takumi T, Gurgenova F, Kawakami H, Bulayev O (2012) Mapping genes related to early onset major depressive disorder in dagestan genetic isolates. Turk Psikiyatri Derg 23:161-170
9. Cai J, Zhang W, Yi Z, Lu W, Wu Z, Chen J, Yu S, Fang Y, Zhang C (2013) Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms. Psychopharmacol (Berl). doi: 10.1007/s00213-013-3137-2
10. Carvalho AF, Cavalcante JL, Castelo MS, Lima MC (2007) Augmentation strategies for treatment-resistant depression: a literature review. J Clin Pharm Ther 32:415-428
11. Duman RS, Aghajanian GK (2012) Synaptic dysfunction in depression: potential therapeutic targets. Science 338:68-72
12. Fagiolini A, Kupfer DJ (2003) Is treatment-resistant depression a unique subtype of depression? Biol Psychiatry 53:640-648
13. Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA (2010) Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population. J Clin Psychopharmacol 30:357-364
14. Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Cui X, Calabrese JR, Gao K (2011) A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression. J Clin Psychopharmacol 31:638-642
15. Gao SF, Bao AM (2011) Corticotropin-releasing hormone, glutamate, and gamma-aminobutyric acid in depression. Neuroscientist 17:124-144
16. Gibson TB, Jing Y, Smith Carls G, Kim E, Bagalman JE, Burton WN, Tran QV, Pikalov A, Goetzel RZ (2010) Cost burden of treatment resistance in patients with depression. Am J Manag Care 16:370-377
17. Gonda X, Fountoulakis KN, Csukly G, Bagdy G, Pap D, Molnar E, Laszik A, Lazary J, Sarosi A, Faludi G, Sasvari-Szekely M, Szekely A, Rihmer Z (2011) Interaction of 5-HTTLPR genotype and unipolar major depression in the emergence of aggressive/hostile traits. J Affect Disord 132:432-437
18. Hashimoto K, Sawa A, Iyo M (2007) Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 62:1310-1316
19. Ibrahim L, Diaz Granados N, Jolkovsky L, Brutsche N, Luckenbaugh DA, Herring WJ, Potter WZ, Zarate CA Jr (2012) A randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder. J Clin Psychopharmacol 32:551-557
20. Kato T (2007) Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci 61:3-19
21. Kayser S, Bewernick BH, Grubert C, Hadrysiewicz BL, Axmacher N, Schlaepfer TE (2011) Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. J Psychiatr Res 45:569-576
22. Kim JH, Park M, Yang SY, Jeong BS, Yoo HJ, Kim JW, Chung JH, Kim SA (2006) Association study of polymorphisms in N-methyl-D-aspartate receptor 2B subunits (GRIN2B) gene with Korean alcoholism. Neurosci Res 56:220-223
23. Laje G, McMahon FJ (2007) The pharmacogenetics of major depression: past, present, and future. Biol Psychiatry 62:1205-1207
24. Li D, He L (2007) Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a HuGE review and meta-analysis. Genet Med 9:4-8
25. Li ZZ, Zhang YX, Wang ZW, Chen J, Fan JB, Guan YT, Zhang C, Yuan CM, Hong W, Wang Y, Wu ZG, Huang J, Hu YY, Cao L, Yi ZH, Cui DH, Yu SY, Fang YR (2013) The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: Data from multicenter, prospective, longitudinal clinic practice. J Psychiatr Res 47:8-14
26. Loftis JM, Janowsky A (2003) The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol Ther 97:55-85
27. O'Reilly RL, Bogue L, Singh SM (1994) Pharmacogenetic response to antidepressants in a multicase family with affective disorder. Biol Psychiatry 36:467-471
28. Preskorn SH, Baker B, Kolluri S, Menniti FS, Krams M, Landen JW (2008) An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. J Clin Psychopharmacol 28:631-637
29. Rhee SH, Waldman ID (2002) Genetic and environmental influences on antisocial behavior: a meta-analysis of twin and adoption studies. Psychol Bull 128:490-529
30. Rush AJ, Thase ME, Dube S (2003) Research issues in the study of difficult-to-treat depression. Biol Psychiatry 53:743-753
31. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M (2006) Acute and longer term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163:1905-1917
32. Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF (2004) Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61:705-713
33. Sanacora G, Treccani G, Popoli M (2012) Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62:63-77
34. Scott J, Dickey B (2003) Global burden of depression: the intersection of culture and medicine. Br J Psychiatry 183:92-94
35. Sokolowski M, Ben-Efraim YJ, Wasserman J, Wasserman D (2013) Glutamatergic GRIN2B and polyaminergic ODC1 genes in suicide attempts: associations and gene-environment interactions with childhood/adolescent physical assault. Mol Psychiatry 18:985-992
36. Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, Kasper S, Lecrubier Y, Montgomery S, Serretti A, Zohar J, Mendlewicz J (2007) Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study. J Clin Psychiatry 68:1062-1070
37. Sullivan PF, Neale MC, Kendler KS (2000) Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157:1552-1562
38. Wang Z, Li Z, Chen J, Huang J, Yuan C, Hong W, Yu S, Fang Y (2012) Association of BDNF gene polymorphism with bipolar disorders in Han Chinese population. Genes Brain Behav 11:524-548
39. Wang Y, Yang Y, Hui L, Tie C, Li F, Xu ZQ, Wang C (2013a) A neuropeptide Y variant (rs16139) associated with major depressive disorder in replicate samples from Chinese Han Population. PLoS One 8:e57042
40. Wang Z, Fan J, Gao K, Li Z, Yi Z, Wang L, Huang J, Yuan C, Hong W, Yu S, Fang Y (2013b) Neurotrophic tyrosine kinase receptor type 2 (NTRK2) gene associated with treatment response to mood stabilizers in patients with bipolar i disorder. J Mol Neurosci 50:305-310
41. Wijeratne C, Sachdev P (2008) Treatment-resistant depression: critique of current approaches. Aust N Z J Psychiatry 42:751-762
42. Zhang X, Zhang C, Wu Z, Wang Z, Peng D, Chen J, Hong W, Yuan C, Li Z, Yu S, Fang Y (2013) Association of genetic variation in CACNA1C with bipolar disorder in Han Chinese. J Affect Disord 150:261-265
43. Zhao QA, Che RL, Zhang Z, Wang P, Li J, Li Y, Huang K, Tang W, Feng GY, Lindpaintner K, He L, Shi YY (2011) Positive association between GRIN2B gene and bipolar disorder in the Chinese Han Population. Psychiatry Res 185:290-292